Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

WEIGHT loss drug Mounjaro would not be good value for money for the health service at its current price, a new study has ...

A new study for the HSE has found that making the weight loss drug Mounjaro available to public patients would not be value ...

A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

YOU may be keen to shed pounds from your waistline with fat jabs, but forking out the monthly bill is less appealing – ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Patients on popular GLP-1 weight-loss and diabetes jabs should be monitored for suicidal behaviour, the TGA says, while ...

The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...